TISSUEGENE
TissueGene is a Maryland-based biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders. Founded in 1999, the company’s core technology employs a form of cell therapy to deliver therapeutic proteins directly to localized areas of damaged tissue. The sustained expression of such proteins initiates rapid repair of injured tissue without the need for invasive surgical procedures. TissueGene is currently developing four product candidates, TG-C, TG-B, TG-D, and TG-N for the regeneration of cartilage, bone, disc, and nerve, respectively. The company's lead product candidate, TG-C, has been developed for treating osteoarthritis of the knee and is currently in Phase II trials in the US and in Phase III trials in Korea.
TISSUEGENE
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1999-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.tissuegene.com
Total Employee:
11+
Status:
Active
Contact:
(301)921-6000
Email Addresses:
[email protected]
Total Funding:
124.73 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Google Analytics LetsEncrypt Amazon SSL By Default Google Universal Analytics
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Panoptes Pharma
Developing innovative small molecule drugs to treat eye diseases with high unmet medical need.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.tissuegene.com Semrush global rank: 7.7 M Semrush visits lastest month: 723
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "TissueGene"
About :: Kolon TissueGene, Inc. (950160)
Kolon TissueGene has developed its unique technology platform in cell and gene therapy over the past 20 years through the development of TG-C. After many years, when cell and gene …See details»
TissueGene - Crunchbase Company Profile & Funding
TissueGene is a Maryland-based biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders. Founded in 1999, the …See details»
Kolon TissueGene, Inc.
About Kolon TissueGene, Inc. Kolon TissueGene, Inc., is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee. ... The …See details»
TissueGene Announces Company Name Change To Kolon …
ROCKVILLE, Md., March 16, 2018 /PRNewswire/ -- TissueGene, Inc. ("the Company"), a leader in advanced cell and gene therapies targeting osteoarthritis (OA), announced today the …See details»
Kolon TissueGene - Overview, News & Similar companies
Dec 27, 2021 Kolon TissueGene, Inc., is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee. Kolon TissueGene's …See details»
TissueGene Announces Company Name Change To Kolon …
ROCKVILLE, Md., March 16, 2018 /PRNewswire/ -- TissueGene, Inc. ("the Company"), a leader in advanced cell and gene therapies targeting osteoarthritis (OA), announced today the …See details»
TissueGene changes name to Kolon TissueGene, Inc.
In July 2017, Kolon Life Science, Inc., TissueGene’s exclusive licensee for Asia, received marketing approval from the South Korea Ministry of Food & Drug Safety (MFDS) for Invossa …See details»
TissueGene - Crunchbase
TissueGene is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders.See details»
TissueGene - Company Profile - Tracxn
Sep 23, 2024 TissueGene ranks 110th among 654 active competitors. 236 of its competitors are funded while 150 have exited. Overall, TissueGene and its competitors have raised over …See details»
TissueGene - Org Chart, Teams, Culture & Jobs | The Org
TissueGene is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders. Industries. Biotechnology, Health Care +1. …See details»
TISSUEGENE, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TISSUEGENE, INC. of Gaithersburg, MD. Get the latest business insights from Dun & Bradstreet.See details»
TissueGene - Overview, News & Similar companies | ZoomInfo.com
TissueGene Inc is a company that operates in the Textiles industry. It employs 11-20 people and has $1M-$5M of revenue. Read More. TissueGene's Social Media. Is this data correct? …See details»
History :: Kolon TissueGene, Inc. (950160)
Founded Kolon TissueGene. June 2000. License Agreement with Kolon Life Science. October 2001. Secured US Patent with TG-C Related Technology (Gene Therapy Utilizing TGF-β1) …See details»
TissueGene - Funding, Financials, Valuation & Investors - Crunchbase
TissueGene is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders. Search Crunchbase. ... How much funding has …See details»
TissueGene - Contacts, Employees, Board Members, Advisors
Organization. TissueGene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 20. ...See details»
TissueGen - Crunchbase Company Profile & Funding
TissueGen may be growing as indicated by several news articles highlighting its activities in the biopharmaceutical industry. One article discusses the expansion of possibilities in implantable …See details»
Kolon TissueGene, Inc. (Kolon TissueGene, Inc.) - 药物管线_专利_临 …
了解Kolon TissueGene, Inc. (Kolon TissueGene, Inc.)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 5篇新闻和1篇文献，疾病领域:神经系统疾病，免疫系统疾病，技术平台: …See details»
Technology :: Kolon TissueGene, Inc. (950160)
At Kolon TissueGene, we have leveraged the science of cell and gene therapy to develop innovative medicines to change the paradigm in how patients are treated. Platform Our …See details»
Product Pipeline :: Kolon TissueGene, Inc. (950160)
TissueGene, is developing four product candidates, InvossaTM (TG-C), TG-B, TG-D and TG-N for the regeneration of cartilage, bone, disc and nerve, respectively.See details»